INVOKAMET
Active substance: CANAGLIFLOZIN, METFORMIN HYDROCHLORIDE
TABLET, FILM COATED · CANAGLIFLOZIN 150 mg/1, METFORMIN HYDROCHLORIDE 1000 mg/1
United StatesActive
Marketing holder: Janssen Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CANAGLIFLOZIN · 150 mg/1
- METFORMIN HYDROCHLORIDE · 1000 mg/1
Products containing canagliflozin in other countries
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-6c5b-7e25-a085-df4b8cd9d822,01a1208c-773f-7cc7-a693-6c227aca8302,01a1208e-587a-7814-a6e1-140c5ae75adc,01a12091-ae05-75d8-b3dc-2ff51dce0c6b,01a12093-8a1e-71ae-a54a-e1f0bfdabc40;count=7 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50458-543
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 50458-543 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50458-543 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50458-543 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 50458-543 · Verified 2026-10-09 · open in source